Drug factory · FDA FEI 3002806754

COSMA Spa

VIA BARTOLOMEO COLLEONI 15/17, Ciserano, Italy

Italy: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 17, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2009: 0 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CetirizineMakes the active ingredient Eyevance Pharmaceuticals 71776-024
MetoclopramideMakes the active ingredient Evoke Pharma, Inc. 72089-307
PropranololTests it Eton Pharmaceuticals, Inc. 71863-132

FDA inspection history

EndedResultProgramProblems noted
Jun 17, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 15, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 22, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 10, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.